Cargando…
Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials
BACKGROUND: Despite recent increased clinical trials activity, no regimen has proved able to replace the standard 6-month regimen for drug-sensitive tuberculosis. Understanding the relationship between microbiological markers measured during treatment and long-term clinical outcomes is critical to e...
Autores principales: | Phillips, Patrick P. J., Mendel, Carl M., Burger, Divan A., Crook, Angela, Nunn, Andrew J., Dawson, Rodney, Diacon, Andreas H., Gillespie, Stephen H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743210/ https://www.ncbi.nlm.nih.gov/pubmed/26847437 http://dx.doi.org/10.1186/s12916-016-0565-y |
Ejemplares similares
-
Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials
por: Phillips, Patrick P. J., et al.
Publicado: (2016) -
A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens
por: Phillips, Patrick P. J., et al.
Publicado: (2017) -
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis
por: Diacon, Andreas H., et al.
Publicado: (2020) -
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status
por: Tweed, Conor D., et al.
Publicado: (2019) -
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
por: Tweed, Conor Duncan, et al.
Publicado: (2018)